• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑胶质瘤干细胞代谢组学分析揭示丙酮酸羧化酶是一个关键的生存因素和潜在的治疗靶点。

Metabolic profiling of glioblastoma stem cells reveals pyruvate carboxylase as a critical survival factor and potential therapeutic target.

机构信息

Nantes Université, Inserm 1307, CNRS 6075, Université d'Angers, Nantes, France.

Faculty of Sciences, Lebanese University, Beirut, Lebanon.

出版信息

Neuro Oncol. 2024 Sep 5;26(9):1572-1586. doi: 10.1093/neuonc/noae106.

DOI:10.1093/neuonc/noae106
PMID:38869884
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11376449/
Abstract

BACKGROUND

Glioblastoma (GBM) is a highly aggressive tumor with unmet therapeutic needs, which can be explained by extensive intra-tumoral heterogeneity and plasticity. In this study, we aimed to investigate the specific metabolic features of Glioblastoma stem cells (GSC), a rare tumor subpopulation involved in tumor growth and therapy resistance.

METHODS

We conducted comprehensive analyses of primary patient-derived GBM cultures and GSC-enriched cultures of human GBM cell lines using state-of-the-art molecular, metabolic, and phenotypic studies.

RESULTS

We showed that GSC-enriched cultures display distinct glycolytic profiles compared with differentiated tumor cells. Further analysis revealed that GSC relies on pyruvate carboxylase (PC) activity for survival and self-renewal capacity. Interestingly, inhibition of PC led to GSC death, particularly when the glutamine pool was low, and increased differentiation. Finally, while GSC displayed resistance to the chemotherapy drug etoposide, genetic or pharmacological inhibition of PC restored etoposide sensitivity in GSC, both in vitro and in orthotopic murine models.

CONCLUSIONS

Our findings demonstrate the critical role of PC in GSC metabolism, survival, and escape to etoposide. They also highlight PC as a therapeutic target to overcome therapy resistance in GBM.

摘要

背景

胶质母细胞瘤(GBM)是一种具有未满足治疗需求的高度侵袭性肿瘤,这可以用广泛的肿瘤内异质性和可塑性来解释。在这项研究中,我们旨在研究胶质母细胞瘤干细胞(GSC)的特定代谢特征,GSC 是一种参与肿瘤生长和治疗耐药的罕见肿瘤亚群。

方法

我们使用最先进的分子、代谢和表型研究方法,对原发性患者来源的 GBM 培养物和人 GBM 细胞系的 GSC 富集培养物进行了全面分析。

结果

我们表明,与分化的肿瘤细胞相比,GSC 富集培养物显示出明显的糖酵解特征。进一步的分析表明,GSC 依赖于丙酮酸羧化酶(PC)活性来维持生存和自我更新能力。有趣的是,抑制 PC 会导致 GSC 死亡,特别是当谷氨酰胺池较低且分化增加时。最后,虽然 GSC 对化疗药物依托泊苷具有耐药性,但 PC 的遗传或药理学抑制在体外和原位小鼠模型中恢复了 GSC 对依托泊苷的敏感性。

结论

我们的研究结果表明 PC 在 GSC 代谢、存活和逃避依托泊苷方面发挥着关键作用。它们还强调了 PC 作为克服 GBM 治疗耐药性的治疗靶点的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e803/11376449/39cde8a8221f/noae106_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e803/11376449/6b35b6a0fc9c/noae106_fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e803/11376449/c22ab44294ec/noae106_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e803/11376449/7ab9d43433a9/noae106_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e803/11376449/003c9437ba42/noae106_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e803/11376449/6b4720008d21/noae106_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e803/11376449/841e45404cde/noae106_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e803/11376449/39cde8a8221f/noae106_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e803/11376449/6b35b6a0fc9c/noae106_fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e803/11376449/c22ab44294ec/noae106_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e803/11376449/7ab9d43433a9/noae106_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e803/11376449/003c9437ba42/noae106_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e803/11376449/6b4720008d21/noae106_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e803/11376449/841e45404cde/noae106_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e803/11376449/39cde8a8221f/noae106_fig6.jpg

相似文献

1
Metabolic profiling of glioblastoma stem cells reveals pyruvate carboxylase as a critical survival factor and potential therapeutic target.脑胶质瘤干细胞代谢组学分析揭示丙酮酸羧化酶是一个关键的生存因素和潜在的治疗靶点。
Neuro Oncol. 2024 Sep 5;26(9):1572-1586. doi: 10.1093/neuonc/noae106.
2
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.在体外和体内杀死胶质母细胞瘤干细胞样细胞需要联合抑制PDK1和CHK1。
Cell Death Dis. 2014 May 8;5(5):e1223. doi: 10.1038/cddis.2014.188.
3
The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy.采用 CUSP9 策略,用九种再利用药物对神经胶质瘤干细胞进行协调的药物阻断的疗效。
J Cancer Res Clin Oncol. 2019 Jun;145(6):1495-1507. doi: 10.1007/s00432-019-02920-4. Epub 2019 Apr 26.
4
The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma.酮体对治疗成人和儿童脑胶质母细胞瘤的糖酵解抑制作用的贡献。
J Neurooncol. 2020 Apr;147(2):317-326. doi: 10.1007/s11060-020-03431-w. Epub 2020 Feb 24.
5
LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.LGR5 促进神经胶质瘤干细胞的致瘤性和侵袭性,是神经胶质瘤患者亚群的潜在治疗靶点。
J Pathol. 2019 Feb;247(2):228-240. doi: 10.1002/path.5186. Epub 2019 Jan 10.
6
Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways.萝卜硫素通过多种细胞信号通路抑制神经胶质瘤细胞、神经胶质瘤干细胞样球体和肿瘤异种移植物的生长。
J Neurosurg. 2017 Dec;127(6):1219-1230. doi: 10.3171/2016.8.JNS161197. Epub 2017 Jan 6.
7
Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.白藜芦醇靶向作用于胶质母细胞瘤和胶质母细胞瘤干细胞中的 AKT 和 p53 以抑制生长和浸润。
J Neurosurg. 2017 May;126(5):1448-1460. doi: 10.3171/2016.1.JNS152077. Epub 2016 Jul 15.
8
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.在神经胶质瘤干细胞中维持原发性肿瘤表型和基因型。
Neuro Oncol. 2012 Feb;14(2):132-44. doi: 10.1093/neuonc/nor195. Epub 2011 Nov 7.
9
4,5-Dimethoxycanthin-6-one Inhibits Glioblastoma Stem Cell and Tumor Growth by Inhibiting TSPAN1 Interaction with TM4SF1.4,5-二甲氧基卡亭-6-酮通过抑制 TSPAN1 与 TM4SF1 的相互作用抑制神经胶质瘤干细胞和肿瘤生长。
Neurochem Res. 2024 Oct;49(10):2897-2909. doi: 10.1007/s11064-024-04211-y. Epub 2024 Jul 26.
10
Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma.活性氧介导的胶质母细胞瘤治疗反应和耐药性。
Cell Death Dis. 2015 Jan 15;6(1):e1601. doi: 10.1038/cddis.2014.566.

引用本文的文献

1
Cancer stem cells: landscape, challenges and emerging therapeutic innovations.癌症干细胞:现状、挑战与新兴治疗创新
Signal Transduct Target Ther. 2025 Aug 5;10(1):248. doi: 10.1038/s41392-025-02360-2.
2
N-phenylmaleimide induces bioenergetic switch and suppresses tumor growth in glioblastoma tumorspheres by inhibiting SLC25A11.N-苯基马来酰亚胺通过抑制SLC25A11诱导生物能量转换并抑制胶质母细胞瘤肿瘤球中的肿瘤生长。
Cancer Cell Int. 2025 May 22;25(1):184. doi: 10.1186/s12935-025-03813-y.
3
LDH Isoenzyme and GAA-BSA Nanoparticles: A Novel Therapy Approach for Proneural Subtype Glioblastoma Multiforme.

本文引用的文献

1
Immunodetection of Pyruvate Carboxylase Expression in Human Astrocytomas, Glioblastomas, Oligodendrogliomas, and Meningiomas.免疫检测人星形细胞瘤、胶质母细胞瘤、少突胶质细胞瘤和脑膜瘤中丙酮酸羧化酶的表达。
Neurochem Res. 2023 Jun;48(6):1728-1736. doi: 10.1007/s11064-023-03856-5. Epub 2023 Jan 20.
2
Neuronal and tumourigenic boundaries of glioblastoma plasticity.胶质母细胞瘤可塑性的神经元和致瘤边界
Trends Cancer. 2023 Mar;9(3):223-236. doi: 10.1016/j.trecan.2022.10.010. Epub 2022 Nov 29.
3
NDRG2 inhibits pyruvate carboxylase-mediated anaplerosis and combines with glutamine blockade to inhibit the proliferation of glioma cells.
乳酸脱氢酶同工酶与糖原脱支酶-牛血清白蛋白纳米颗粒:一种针对神经干细胞样亚型多形性胶质母细胞瘤的新型治疗方法。
J Cancer. 2025 Jan 6;16(4):1101-1117. doi: 10.7150/jca.98452. eCollection 2025.
4
The Impact of Metabolic Rewiring in Glioblastoma: The Immune Landscape and Therapeutic Strategies.代谢重编程在胶质母细胞瘤中的影响:免疫格局与治疗策略
Int J Mol Sci. 2025 Jan 14;26(2):669. doi: 10.3390/ijms26020669.
5
Inhibiting glioblastoma stem cells by targeting pyruvate carboxylase: A novel therapeutic strategy with both opportunities and challenges.通过靶向丙酮酸羧化酶抑制胶质母细胞瘤干细胞:一种机遇与挑战并存的新型治疗策略。
Neuro Oncol. 2025 Feb 10;27(2):589-590. doi: 10.1093/neuonc/noae250.
6
Inhibiting glioblastoma stem cells by targeting pyruvate carboxylase: a novel therapeutic strategy with both opportunities and challenges.通过靶向丙酮酸羧化酶抑制胶质母细胞瘤干细胞:一种机遇与挑战并存的新型治疗策略。
Neuro Oncol. 2025 Feb 10;27(2):586-588. doi: 10.1093/neuonc/noae249.
7
Agonists and Inhibitors of the cGAS-STING Pathway.cGAS-STING 通路的激动剂和抑制剂。
Molecules. 2024 Jun 30;29(13):3121. doi: 10.3390/molecules29133121.
NDRG2抑制丙酮酸羧化酶介导的回补反应,并与谷氨酰胺阻断相结合以抑制胶质瘤细胞的增殖。
Am J Cancer Res. 2022 Aug 15;12(8):3729-3744. eCollection 2022.
4
Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression.胶质瘤异质性的时空分析揭示 COL1A1 可作为破坏肿瘤进展的治疗靶点。
Nat Commun. 2022 Jun 24;13(1):3606. doi: 10.1038/s41467-022-31340-1.
5
ADAR1-mediated RNA editing links ganglioside catabolism to glioblastoma stem cell maintenance.ADAR1 介导的 RNA 编辑将神经节苷脂代谢与神经胶质瘤干细胞维持联系起来。
J Clin Invest. 2022 Mar 15;132(6). doi: 10.1172/JCI143397.
6
Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia.线粒体抑制剂规避了 venetoclax 和阿糖胞苷联合治疗急性髓系白血病的适应性耐药。
Nat Cancer. 2021 Nov;2(11):1204-1223. doi: 10.1038/s43018-021-00264-y. Epub 2021 Nov 11.
7
Wild-type isocitrate dehydrogenase under the spotlight in glioblastoma.野生型异柠檬酸脱氢酶成为胶质母细胞瘤研究焦点
Oncogene. 2022 Jan;41(5):613-621. doi: 10.1038/s41388-021-02056-1. Epub 2021 Nov 11.
8
Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells.转录延伸机器是一种可药物化的依赖性,并增强胶质母细胞瘤干细胞中的免疫治疗。
Cancer Discov. 2022 Feb;12(2):502-521. doi: 10.1158/2159-8290.CD-20-1848. Epub 2021 Oct 6.
9
Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in Glioblastoma.单细胞分析揭示YAP/TAZ是胶质母细胞瘤干性和细胞可塑性的调节因子。
Nat Cancer. 2021 Feb;2(2):174-188. doi: 10.1038/s43018-020-00150-z. Epub 2020 Dec 7.
10
Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43.通过 TAT-Cx43 特异性抑制 c-Src 靶向体外和体内神经胶质瘤干细胞的代谢可塑性
EBioMedicine. 2020 Dec;62:103134. doi: 10.1016/j.ebiom.2020.103134. Epub 2020 Nov 27.